‘Half a million’ GP hours freed for patients
The three-year extension is part of a £30 million investment in a national programme for General Practice Development.
16th April 2019
Latest news
FDA approves first targeted therapy for metastatic bladder cancer
The decision was based on a clinical trial showing an objective response rate of 32.2%.
16th April 2019
BMS, Celgene shareholders back mega merger
The decision was won by a majority of more than 75%.
16th April 2019
AZ finds lack of lung cancer info available for patients
Available information is often outdated and sometimes inaccurate.
15th April 2019
Data show J&J’s Invokana may slow or prevent CKD in diabetes patients
The data provides the first significant update in nearly 20 years regarding slowing the progression of CKD in patients with type II diabetes.
15th April 2019
EMA recommends temporarily restricting Lemtrada use in MS
The review comes following new reports of immune-mediated conditions.
15th April 2019
Gilead announces Novo Nordisk NASH partnership after new data revealed
The companies will collaborate for a clinical trial combining compounds from their respective pipelines in NASH.
15th April 2019
‘Concerning’ levels of non-alcoholic fatty liver disease among young people
A new study has shown an alarmingly high prevalence of non-alcoholic fatty liver disease in young adults.
15th April 2019
The Creative Engagement Group ‘strengthens’ offerings, launches Axiom in Europe
The division will combine the Healthcare Communications team in the UK with the US Axiom team.
15th April 2019
MSD’s Keytruda granted FDA extension
The approval is based on results from the Phase III KEYNOTE-042 trial.
12th April 2019
Latest NHS stats show “strain on an already overstretched system”
Performance improves in some areas and ambulance response times hit target for the first time ever, but A&E admittances are continuing to rise and cancer patients are still waiting too long for treatment.
12th April 2019
New Brexit date is a ‘relief’, says NHS Confederation
The UK has been granted a six-month Brexit extension to October 31.
12th April 2019
Maintenance immunotherapy disappoints in SCLC
A trial found that overall survival was not significantly prolonged with combination immunotherapy, or with nivolumab alone.
12th April 2019
EMA confirms path for Diurnal's Chronocort despite trial failure
The company is on track to submit a Marketing Authorisation Application in the fourth quarter of 2019.
12th April 2019
Medidata launches Acorn AI
The company aims to accelerate the digital transformation of life sciences in the age of precision medicine.
12th April 2019
